https://pittplusme.org/study/2120
NASH GC41033 Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Are you 18-75 and diagnosed with a type of liver disease called non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH)? You may be able to participate in a study to compare the effects, good or bad, of a drug called BFKB8488A versus placebo. A placebo looks like a drug but has no active ingredient. This study involves 29 visits over 16 months. Compensation is provided.
IRB: 20191742
- A PHASE II, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF BFKB8488A COMPARED WITH PLACEBO IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS
AGE:
18-75
DURATION:
16 months
VISITS:
About 29
LOCATION:
UPMC Center for Liver Diseases - Oakland
COMPENSATION:
$75 per completed visit
SHARE STUDY
